SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?


To: paret who wrote (716110)12/1/2005 4:34:52 AM
From: DuckTapeSunroof  Respond to of 769667
 
Pot May Help Grow Brain Cells:

Friday, October 21, 2005
drugpolicy.org

A new study indicates that the cannabinoid compound in marijuana could be good for the brain, as well as treat mood disorders. A report in the November issue of the Journal of Clinical Investigation suggests that unlike other drugs such as nicotine and heroin, which suppress the development of brain cells, cannabinoids do not damage neurons, and in fact promote their growth.

In a study by researchers at the University of Saskatchewan, rats were given both short-term and longer-term (two-week) treatment with high doses of cannabinoids. The rats undergoing the longer treatment responded to tests in ways that indicated reduced anxiety. One such test involved depriving the rats of food for 48 hours. When food was reintroduced in an unfamiliar environment, the treated rats began eating much more quickly. The researchers note that this was not due to the appetite stimulation associated with marijuana, because the treated and untreated rats had similar eating patterns when they were given food in a familiar setting.

The study also found that treated rats showed less anxiety and spent less time immobile when undergoing stressful swimming and climbing tests, which the researchers interpreted as evidence of an anti-depressant effect. They point to the hippocampus, the part of the brain where the neural growth occurred, which is important in regulation of mood disorders.

Dr. Xia Zhang, who led the study, cautions that these effects will still need to be examined in humans. If the results are the same, Zhang anticipates long-term clinical use of marijuana for anxiety and depression.



To: paret who wrote (716110)12/1/2005 4:37:42 AM
From: DuckTapeSunroof  Respond to of 769667
 
Marijuana might cause new cell growth in the brain

22:00 13 October 2005
NewScientist.com news service
Kurt Kleiner

A synthetic chemical similar to the active ingredient in marijuana makes new cells grow in rat brains. What is more, in rats this cell growth appears to be linked with reducing anxiety and depression. The results suggest that marijuana, or its derivatives, could actually be good for the brain.

In mammals, new nerve cells are constantly being produced in a part of the brain called the hippocampus, which is associated with learning, memory, anxiety and depression. Other recreational drugs, such as alcohol, nicotine and cocaine, have been shown to suppress this new growth. Xia Zhang of the University of Saskatchewan in Saskatoon, Canada, and colleagues decided to see what effects a synthetic cannabinoid called HU210 had on rats' brains.

They found that giving rats high doses of HU210 twice a day for 10 days increased the rate of nerve cell formation, or neurogenesis, in the hippocampus by about 40%.
Just like Prozac?

A previous study showed that the antidepressant fluoxetine (Prozac) also increases new cell growth, and the results indicated that it was this cell growth that caused Prozac’s anti-anxiety effect. Zhang wondered whether this was also the case for the cannabinoid, and so he tested the rats for behavioural changes.

When the rats who had received the cannabinoid were placed under stress, they showed fewer signs of anxiety and depression than rats who had not had the treatment. When neurogenesis was halted in these rats using X-rays, this effect disappeared, indicating that the new cell growth might be responsible for the behavioural changes.

In another study, Barry Jacobs, a neuroscientist at Princeton University, gave mice the natural cannabinoid found in marijuana, THC (D9-tetrahydrocannabinol)). But he says he detected no neurogenesis, no matter what dose he gave or the length of time he gave it for. He will present his results at the Society for Neuroscience meeting in Washington DC in November.

Jacobs says it could be that HU210 and THC do not have the same effect on cell growth. It could also be the case that cannabinoids behave differently in different rodent species - which leaves open the question of how they behave in humans.

Zhang says more research is needed before it is clear whether cannabinoids could some day be used to treat depression in humans.

Journal reference: Journal of Clinical Investigation (DOI:10.1172/JCI25509)
Related Articles

* Cannabis may soothe inflamed bowels
* newscientist.com
* 01 August 2005
* Cannabis and schizophrenia link blurs further
* newscientist.com
* 16 April 2005
* Cannabis: Too much, too young?
* newscientist.com
* 26 March 2005

Weblinks

* Paper by Zhang et al
* the-jci.org
* University of Saskatchewan Neural Systems and Plasticity Research Group
* usask.ca
* Barry Jacobs, Princeton University
* webscript.princeton.edu
* Drugs and alcohol, New Scientist
* newscientist.com
* Journal of Clinical Investigation
* jci.org



To: paret who wrote (716110)12/1/2005 4:42:54 AM
From: DuckTapeSunroof  Respond to of 769667
 
Drugs and Alcohol: Instant Expert

(Web site links to research for all substances mentioned below)
newscientist.com


People have been using substances to lift their spirits for millennia. Techniques for fermenting beer and related tipples are known from Egypt and Sumeria 4000 years ago, and they soon spread across the inhabited world. Coca leaves (the source of cocaine), tobacco, and caffeine were also popular with ancient cultures.

Humans may even have an evolutionary pre-disposition to seek out narcotics, even though they can be addictive and damaging. Some people may have genes which make them more genetically prone to drug addiction than others. Even some animals - jaguars, lemurs and bees, for example - have a habit of getting high.

There is an enormous amount of research on drug taking, examining both legal highs, such as alcohol, nicotine and caffeine, and illegal stimulants, such as marijuana, LSD, cocaine, ecstasy, amphetamines, heroin and magic mushrooms and the so-called date-rape drugs rohypnol and GHB.

Alcohol - Some experts believe that the world's first impromptu breweries might have been created when grain stores became drenched with rain and warmed in the sun. Ever since, humans have discovered that alcohol reduces their inhibitions, impairs their judgement, affects sexual desire and performance, creates beer bellies and leads to hangovers (and dubious cures).

Binge drinking is an ever-increasing health concern, and when not consumed in moderation, alcohol can lead to liver problems, brain damage and infertility. Drinking whilst pregnant can also damage the unborn child. It is not all bad news though: studies show that some types of booze, such as red wine, are rich in antioxidant polyphenols which can help prevent heart disease and cancer.

Marijuana, once the preserve of hippies, is now regularly smoked by millions of people in the US and UK. Around 14.6 million Americans have used marijuana in the last 30 days. Though still controversial, support for controlled legalisation of this most common illegal drug is growing.

That support is bolstered by research showing that cannabis (and psychoactive extracts such as THC or cannabinoids) can provide relief for sufferers of multiple sclerosis, Alzheimer's disease and epilepsy. Cannabis can also help to improve appetite and decrease weight loss in AIDS victims and may be able to slow the growth of cancerous tumours.

However, detractors argue that the long-term effects of smoking dope on the brain are unclear, that it decreases fertility, damages the unborn foetus, can contribute to cot death in babies born to dope-smoking parents, and may lead to memory loss, schizophrenia, depression and other illnesses.

Ecstasy, or MDMA, was allegedly first prescribed as an anti-depressant. It was also used by American marriage counsellors and psychotherapists in the 1970s. The drug made patients feel less anxious and more open, accepting and empathic. But notoriety for the drug in the UK did not come until it was popularised by the rave dance scene in fields and warehouses in the late 1980s. Use of the drug is now common in main stream clubs and 2 million or more British youngsters pop the tablets at weekends. Clubbers enjoy the feelings of emotional closeness, rushes of energy, increased stamina heightened sense of touch and other effects.

Critics say that regular ecstasy use is a recipe for causing memory loss and lasting damage to the brain's serotonin-producing neurons. Users can die from fatal overheating or a dangerous build-up of water on the brain. Ecstasy causes other problems such as stifling sex drive and damaging babies in the womb.

Tablets contaminated with other compounds are part of the problem and many tests have been developed to check for purity. Controversial research found evidence of a link between ecstasy and Parkinson's disease in 2002, though the finding was later retracted. Other animal studies conversely hinted that ecstasy might actually help treat the symptoms of Parkinson's disease. Some experts point to the fact that despite the drug's massive popularity, ecstasy deaths remain extremely rare: downhill skiing kills more people. Controversial medical trials are testing the use of MDMA to treat post-traumatic stress disorder in victims of rape and violent crime.

Cocaine comes from the coca plant, the leaves of which have been used by Native South Americans for 3000 years as a mild stimulant. Cocaine itself was first developed as a local anaesthetic, but has been a popular street drug since the 1970s. Today it is used by millions of people in the US alone and up to 150,000 end up in emergency rooms with heart attacks or other side effects. It acts on the brain's dopamine system, and is thought to mimic the thrill of desire and anticipation.

Cocaine is highly addictive - many users become dependent after a year or two, and some research suggests that

just a single dose could get you hooked. Use of the drug is linked to high blood pressure, deadly heart conditions and violent behaviour. Therapies to help addicts conquer their dependence include vaccines and related methods, which use antibodies to bind cocaine and stop it reaching its target in the brain. Other drugs can block cocaine cravings.

Nicotine comes from the leaves of the tobacco plant and was first cultivated and used by Native Americans 8000 years ago. Early European settlers in the Americas cultivated it as a cash crop for export, and smoking became popular back home in Europe during the 1600s. These days, an estimated 46 million Americans smoke 420 billion cigarettes per year. Smoking was thought to have few ill effects until researchers noticed that lung cancer prevalence rose enormously, along with the popularity of cigarette smoking in the twentieth century.

Today the 40-plus known carcinogenic chemicals in tobacco smoke are linked to cancers including those of the stomach, lung, pancreas, cervix and kidney. Research has also shown that nicotine or other tobacco chemicals can increase the speed of growth of tumours, cause cot death in the children of smokers, kill brain cells and lead to heart disease, strokes, emphysema and even mental illness.

Passive smoking is also widely thought to be dangerous activity and has been linked to an increase in cancers, heart disease and stroke, as well as lower than average IQ levels in children. Some people may be genetically-prone to nicotine addiction, and teenagers are more likely to become addicted than adults. Scientists are developing a controversial vaccine which could be used to protect young people against cigarette addiction.

Caffeine is found in around 60 known plant species, is a key ingredient of coffee, tea and chocolate, and is the world's most popular stimulant. Tea has been popular in China for at least 3000 years, but possibly for much longer. Caffeine is used by billions of people to boost alertness.

The drug increases blood pressure and stimulates the heart lungs and other organs. There have been few verifiable links between caffeine and serious health problems, though research has shown it can increase sensitivity to pain, cause panic attacks and play havoc with sleep cycles. Some role in heart disease and cancer has been suggested, but not proven. Research has hinted that caffeine perhaps offers some unusual benefits by protecting against diabetes and radiation poisoning. Critics argue that addictive caffeine - supposedly a flavouring - is used by soft drink manufacturers to keep punters coming back for more.

John Pickrell, 13 December 2004



To: paret who wrote (716110)12/1/2005 4:45:08 AM
From: DuckTapeSunroof  Respond to of 769667
 
Smoking is bad for the brain

16:44 10 December 2004
Exclusive from New Scientist Print Edition
Duncan Graham-Rowe
newscientist.com

Given the wealth of evidence that smoking damages your health, you would have to be stupid not to kick the habit. Now a study suggests this could be a self-fulfilling prophecy, because smoking reduces your IQ.

Lawrence Whalley at the University of Aberdeen and colleagues at the University of Edinburgh, both in the UK, looked at how the cognitive ability of 465 individuals, approximately half of whom were smokers, changed over their lifetime and whether this related to their smoking habits.

They had all been tested in 1947 at age 11 as part of the Scottish Mental Survey, which made no distinction between smoking habits. They were tested a second time between 2000 and 2002, when they were 64 years old.

Smokers performed significantly worse in five different cognitive tests than did both former smokers and those who had never smoked. When social and health factors such as education, occupation and alcohol consumption were taken into account, smoking still appeared to contribute to a drop in cognitive function of just under 1%.

A link between impaired lung function and cognitive ageing has long been suspected, though the mechanism is unclear. One possibility is that smoking subjects the vital organs, including the brain, to oxidative stress, Whalley says. “Ageing neurons are very sensitive to oxidative damage.”

Journal reference: Addictive Behaviors (vol 30, p 77)



To: paret who wrote (716110)12/1/2005 4:46:15 AM
From: DuckTapeSunroof  Read Replies (1) | Respond to of 769667
 
Alcohol may help cancers grow

18 December 2004
Andy Coghlan
Magazine issue 2478

Adding alcohol to cancerous tumours increases their growth rate, animal experiments reveal, though it has not been found to initiate cancers

ALCOHOL may accelerate the growth and spread of existing cancers as well as causing certain types of tumour. The finding may also explain why heavy drinkers often have red noses.

There are well-established links between heavy drinking and various forms of cancer, especially if people smoke as well. The main organs affected are those which bear the brunt of the alcohol exposure: the mouth, throat, stomach and liver. How alcohol makes cancer start and spread has been a mystery, although some experts think that the culprits are substances formed as alcohol breaks down, such as acetaldehyde.

To find out if alcohol also affects existing cancers, Jian-Wei Gu's team at the University of Mississippi Medical Center in Jackson, Mississippi, injected chick embryos in eggs with human fibrosarcoma cells, like those which cause bone and muscle cancers. Then he injected salty water into half the eggs and alcohol into the rest, at ....

newscientist.com



To: paret who wrote (716110)12/1/2005 4:49:38 AM
From: DuckTapeSunroof  Respond to of 769667
 
Speaking of 'brain scans':

Porn panic over eroto-toxins

27 November 2004
From New Scientist Print Edition.
newscientist.com

Pornography, the US Senate was told on 18 October, is a drug more dangerous than crack cocaine. That, at least, was the opinion of some witnesses invited to testify on "the science behind pornography addiction". It's not a view shared by everyone.

Mary Anne Layden, co-director of the sexual trauma and psychopathology programme at the University of Pennsylvania, said unpublished research showed that "even non-sex-addicts will show brain reactions on PET scans while viewing pornography similar to cocaine addicts looking at images of people taking cocaine". Jeffrey Satinover, a doctor whose website outlines therapies for homosexuals, described porn as a designer drug, delivered efficiently over the internet, which "does what heroin can't do". A third expert witness said there was an urgent need for research on addiction to "eroto-toxins".

Porn, like sex, can trigger the release of natural opioids, which have a feel-good effect. But Joe Herbert, a neuroscientist at the University of Cambridge and former president of the International Academy of Sex Research, takes issue with the use of the label "eroto-toxins" and the implication that these chemicals are somehow harmful. "What evidence is there for that?" he asks. "This is saying sex is naughty and you shouldn't do it." The brain lights up in response to the sight of any reward. To conclude that this means porn can be compared to hard drugs is "complete rubbish", he says.



To: paret who wrote (716110)12/1/2005 4:52:34 AM
From: DuckTapeSunroof  Respond to of 769667
 
Fetal Alcohol Syndrome (FAS) is the leading preventable cause of mental retardation in children in the US:

Drug could protect unborn babies against booze

22:00 09 June 2003
NewScientist.com news service
Catherine Zandonella
newscientist.com

A drug to protect unborn babies from the harm caused their mother's excessive drinking is a step closer, with the discovery of a specific way to block alcohol's toxicity.

Fetal Alcohol Syndrome (FAS) is the leading preventable cause of mental retardation in children in the US, affecting up to three babies in every 1000 births. While stopping drinking is the most obvious solution, alcoholic mothers can find this very difficult - motivational programs have historically only been about 30 per cent effective.

A protective drug remains some years away, but the latest research shows how the fetal brain could specifically be shielded from alcohol. Michael Charness at Harvard Medical School and his colleagues found that a protein fragment called NAP stops alcohol from thwarting neurons' ability to connect to each other during brain development.

Earlier work by the team found that alcohol interferes with L1, a protein that allows neurons to stick to one another (New Scientist print edition, 28 September 2002). Also, scientists at the US National Institutes of Health have showed that NAP could abolish FAS in mice.
Side effects

But it was unclear whether NAP specifically blocked alcohol's neurotoxicity, or resulted from NAP's known ability to protect against neurological insults. Determining which was the case was important, as the more precise the action of a drug, the fewer side effects are likely to be seen.

But teasing out the anti-alcohol effect from the overall neuroprotective effect required some complex lab work, involving the creation of a series of slightly different NAP variants. Charness and colleagues then tested these and found one compound that protected mouse embryos in culture from ethanol but offered no protection against another neurotoxin called tetrodotoxin.

This showed that NAP blocks specifically blocks ethanol toxicity. Furthermore, only a very small amount of NAP was needed for protection, again meaning fewer side effects.
Magic bullet

Mary Velasquez, a behavioural researcher at the University of Texas-Houston Health Sciences Center, says a drug would certainly be welcome among women at risk of FAS. "All the clients I see are looking for a magic bullet," she said.

But she expressed reservations about any treatment that would allow a woman to keep drinking throughout pregnancy because of the numerous other social and health-related effects of alcohol.

Some recent studies have reported that even light drinking may cause decreased attention span, poor motor skills and poor emotional development in babies. But the UK agency Alcohol Concern advises that drinking one or two units once or twice a week is very unlikely to cause harm.

Journal reference: Proceedings of the National Academy of Sciences (DOI: 10.1073/pnas.1331636100)
Related Articles

* Alcoholic blackouts may lead to heavier drinking
* newscientist.com
* 14 April 2003
* New white wine has red's health benefits
* newscientist.com
* 12 December 2002
* One drink per day boosts breast cancer risk
* newscientist.com
* 12 November 2002

Weblinks

* Fetal Alcohol Syndrome, CDC
* cdc.gov
* Fetal Alcohol Syndrome, UK
* fasstar.com
* US National Institute on Alcohol Abuse and Alcoholism
* niaaa.nih.gov
* Alcohol Concern, UK
* alcoholconcern.org.uk
* Proceedings of the National Academy of Sciences
* pnas.org



To: paret who wrote (716110)12/1/2005 4:54:32 AM
From: DuckTapeSunroof  Respond to of 769667
 
Alcohol's link to cancer explained

13 August 2005
From New Scientist Print Edition.
newscientist.com

ALCOHOL triggers certain types of cancer, but it has never been clear how - until now.

Studies have suggested that high concentrations of acetaldehyde, which is produced as the body breaks down ethanol, could damage DNA in healthy cells. Now researchers at the National Institute on Alcohol Abuse and Alcoholism in Bethesda, Maryland, have added weight to this idea by showing that the damage occurs at concentrations of acetaldehyde similar to those in saliva and the gastrointestinal tract while people drink alcohol.

Acetaldehyde appears to react with polyamines - naturally occurring compounds essential for cell growth - to create a particularly dangerous type of mutagenic DNA base called a Cr-Pdg adduct, according to Philip Brooks, who led the research (Nucleic Acids Research, DOI: 10.1093/nar/gki661).

"The result is a working model of the mechanism by which alcohol consumption increases the risk of cancer, particularly upper-gastrointestinal cancer," he says.

If these results can be replicated in experiments using living cells, it could pave the way for investigations into how genetic factors, particularly those that influence DNA repair pathways, are related to alcohol consumption and cancer.



To: paret who wrote (716110)12/1/2005 4:58:51 AM
From: DuckTapeSunroof  Read Replies (1) | Respond to of 769667
 
River flowing with cocaine indicates 'vast' drug use

15:53 05 August 2005
NewScientist.com news service
Shaoni Bhattacharya
newscientist.com

A “vastly larger” number of people than thought may abuse cocaine, suggest the results of a study measuring a breakdown product of the illegal drug in an Italian river.

Levels of a cocaine residue excreted in human urine were measured in the River Po, Italy’s largest river. The river has a catchment basin for about five-million people, with major cities like Turin and Milan situated in the valley.

The equivalent of about 4 kilograms of cocaine flowed in the river each day, say the researchers from Mario Negri Institute for Pharmacological Research in Milan, and the University of Insubria in Varese.

The analysis indicates that at least 40,000 packets of the drug are snorted each day – 80 times more than the official estimate of just 15,000 doses taken per month by people living in the area. If the study’s estimates are true, a staggering $150 million in street value of cocaine is dealt each year in the valley, say the researchers.

“Our data suggest that actual cocaine consumption may be much greater than estimated by current methods,” say the researchers. “This is a striking result, considering that…the method employed and the assumptions made could only lead to underestimated consumption figures.”
Panicked traffickers

“We were surprised. However we are quite confident about our results,” says Ettore Zuccato, at Mario Negri, who led the study. “This because we measured cocaine and the metabolite benzoylecgonine and compared their ratio.”

The team sampled water from the river at one site on four different days. They also took samples from waste water flowing into water treatment plants serving the medium-sized cities of Cagliari, Latina, Cuneo and Varese. They measured the cocaine and benzoylecgonine levels, which is found in human urine, using mass spectrometry.

The high estimate of cocaine use is still likely to be too low, believe the researchers. This is because some of the cocaine and its metabolites are likely to be lost or degraded before they had reached the sampling sites.

The team thinks panicked traffickers hastily flushing their goods down the toilet is “highly unlikely” to contribute to their estimates, which are based on multiple samplings. Any dumping of cocaine would be picked up by a rise in the cocaine to benzoylecgonine ratio.
Local trends

Zuccato says he hopes the new method, which is first time illegal drug use has been monitored in this way, could be used to assess the use of other street drugs. “Our method has the potential to monitor local drug abuse trends in real time,” he told New Scientist.

But he notes the technique still has drawbacks. “It is quite expensive and needs very sophisticated analytical instrumentation. It also needs several samplings, and this means a lot of work.”

Current public health measures of illegal drug abuse, are based on surveys, medical records and crime statistics.

Journal reference: Environmental Health (DOI:10.1186/1476-069X-4-14)

Weblinks

* Mario Negri Institute for Pharmacological Research (in Italian)
* marionegri.it
* Environmental Health
* ehjournal.net



To: paret who wrote (716110)12/1/2005 5:01:23 AM
From: DuckTapeSunroof  Respond to of 769667
 
Cannabis truly helps multiple sclerosis sufferers

16:37 10 September 2004
NewScientist.com news service
Anna Gosline, Exeter
newscientist.com

Cannabis may loosen the stiff and spastic muscles of multiple sclerosis sufferers, and not just their minds, a follow-up study has found.

The results contradict findings from the first phase of the study, where improvements seemed to be largely due to "good moods".

“There does seem to be evidence of some benefit from cannabis in the longer term that we didn’t anticipate in the short term study,” says John Zajicek, at Peninsula Medical School in Exeter, UK, and one of the research team.

In 2003, Zajicek and his colleagues published results on the largest study to date of cannabinoids and MS. The trial included 630 advanced-stage MS patients who took either cannabinoid compounds or a placebo for 15 weeks.

Compared with those on placebos, patients who received active compounds said they both felt less pain and less muscle spasticity – the spasms characteristic of this neurodegenerative disease.
Good guess

But physiotherapists using standard evaluations were unable to corroborate the patients' claims of improved mobility or muscle stiffness.

The results were further complicated because about two thirds of the patients who received cannabis compounds, such as D9-tetrahydrocannabinol (THC), guessed they had not received a placebo, due to the drugs effect on their mind.

The knowledge that they were receiving an active compound, along with the mood-altering effects of THC, may have explained why subjects reported improvements.

“If you’ve got a drug that elevates mood and makes people feel better, how can you be sure that it’s really affecting their underlying disease and their symptoms?” asks Zajicek.
Marked improvement

When the short-term study ended, however, the researchers gave all subjects the opportunity to continue their treatment for a full year. The team wanted to extend the study to gather information on the safety of long-term cannabinoid use.

More than 500 patients agreed to stay on their original treatment. One group took pills of D9-tetrahydrocannabinol (THC), the active ingredient in cannabis. The second group received natural cannabis extract, and the third group took a placebo.

At the end of the 12 month period, the patients were evaluated again using the same measures as in the first study. But this time, physiotherapists saw a marked improvement for subjects on active drugs. They had reduced muscle spasticity and an improved overall score for their level of disability.

Zajicek is cautious about the implications of the study as it was not specifically designed to test the efficacy of drugs over 12 months. But the results do support animal research that shows cannabinoids may slow nerve cell death and protect against damage.

The findings were presented at the British Association for the Advancement of Science Festival, in Exeter, UK.

Weblinks

* Multiple Sclerosis Society, UK
* mssociety.org.uk
* Peninsula Medical School, Exeter
* pms.ac.uk
* British Association for the Advancement of Science Festival, Exeter
* the-ba.net



To: paret who wrote (716110)12/1/2005 5:03:28 AM
From: DuckTapeSunroof  Respond to of 769667
 
Cannabis extract shrinks brain tumours

05:00 15 August 2004
NewScientist.com news service
Shaoni Bhattacharya
newscientist.com


Cannabis extracts may shrink brain tumours and other cancers by blocking the growth of the blood vessels which feed them, suggests a new study.

An active component of the street drug has previously been shown to improve brain tumours in rats. But now Manuel Guzmán at Complutense University, Spain, and colleagues have demonstrated how the cannabis extracts block a key chemical needed for tumours to sprout blood vessels – a process called angiogenesis.

And for the first time, the team has shown the cannabinoids impede this chemical in people with the most aggressive form of brain cancer - glioblastoma multiforme.

Cristina Blázquez at Complutense University, and one of the team, stresses the results are preliminary. “But it’s a good point to start and continue,” she told New Scientist.

“The cannabinoid inhibits the angiogenesis response - if a tumour doesn’t do angiogenesis, it doesn’t grow,” she explains. “So if you can improve angiogenesis on one side and kill the tumour cells on the other side, you can try for a therapy for cancer.”

"This research provides an important new lead compound for anti-cancer drugs targeting cancer's blood supply,” says Richard Sullivan, head of clinical programmes, at Cancer Research UK.
Fat molecule

The team tested the effects of delta-9-tetrahydrocannabinol in 30 mice. They found the marijuana extract inhibited the expression of several genes related to the production of a chemical called vascular endothelial growth factor (VEGF).

VEGF is critical for angiogenesis, which allows tumours to grow a network of blood vessels to supply their growth. The cannabinoid significantly lowered the activity of VEGF in the mice and two human brain cancer patients, the study showed.

The drug did this by increasing the activity of a fat molecule called ceramide, suggests the study, as adding a ceramide inhibitor stifled the ability of the cannabinoid to block VEGF.
Small and pallid

“We saw that the tumours [in mice] were smaller and a bit pallid,” adds Blázquez. The paleness of the cancer reflected its lack of blood supply as a result of the treatment. In the human patients, she says: "It seems that it works, but it's very early."

Sullivan points out: “Although this work is at an early stage of development other research has already demonstrated that VEGF is an important drug target for a range of cancers.”

He emphasises the need for further work on cannabinoid combinations. “Cannabinoids would need to generate very strong data in the future as there are already a number of VEGF inhibitors in clinical development,” he says.

The two patients in the ongoing study are among 14 in a clinical trial of the drug. The patients are given one cycle of treatment, lasting a few days, and their survival and general health are being studied.

Journal reference: Cancer Research (vol 64, p 5617)
Related Articles

* Cannabis can help MS sufferers
* newscientist.com
* 07 November 2003
* Cannabis drugs pass testing 'milestone'
* newscientist.com
* 05 November 2002
* Breast cancer spreads by hijacking body’s drainage network
* newscientist.com
* 01 February 2001

Weblinks

* American Association for Cancer Research
* aacr.org
* Cancer Research UK
* cancerresearchuk.org
* Primary brain tumours, MedlinePlus
* nlm.nih.gov
* Cancer Research
* cancerres.aacrjournals.org



To: paret who wrote (716110)12/1/2005 5:11:01 AM
From: DuckTapeSunroof  Respond to of 769667
 
Cannabis may help keep arteries clear

16 April 2005
From New Scientist Print Edition.
newscientist.com

EATING low doses of THC, the active ingredient in cannabis, helps prevent arteries clogging up, at least in mice.

THC binds to two receptors in the body. One is found mostly on brain cells and is responsible for the chemical's psychotropic effects. The other receptor is found mostly on immune cells, and THC has been shown to suppress the immune response to infections and cancer.

François Mach at University Hospital in Geneva, Switzerland, wondered if this effect might also help prevent the build-up of fatty deposits in arteries, or atherosclerosis, by reducing the inflammation associated with this process. Sure enough, when his team fed 1 milligram of THC per kilogram of bodyweight - a low dose that should not have any psychotropic effects - to mice susceptible to atherosclerosis, it greatly slowed the progress of the disease (Nature, vol 434, p 782).

The results are striking, says Michael Roth of the University of California, Los Angeles, who wrote a commentary for Nature. He stresses that the findings do not prove that smoking cannabis will prevent atherosclerosis, pointing out that the mouse study suggests the effect is dose-dependent and too little or too much THC has no protective effect.

Rather than feeding people THC, Roth says, researchers should try to develop drugs that bind only to the cannabinoid receptor found on immune cells.



To: paret who wrote (716110)12/1/2005 5:14:31 AM
From: DuckTapeSunroof  Read Replies (1) | Respond to of 769667
 
Index of medical conditions:

rxmarihuana.com



To: paret who wrote (716110)12/1/2005 5:23:27 AM
From: DuckTapeSunroof  Respond to of 769667
 
Who Supports Marijuana Legalization?

Support rising; varies most by age and gender

The Gallup Poll; November 1, 2005
By Joseph Carroll, Gallup Poll Assistant Editor
mpp.org

Since the late 1960s, Gallup has periodically asked Americans whether the use of marijuana should be made legal in the United States. Although a majority of Americans have consistently opposed the idea of legalizing marijuana, public support has slowly increased over the years. In 1969, just 12% of Americans supported making marijuana legal, but by 1977, roughly one in four endorsed it. Support edged up to 31% in 2000, and now, about a third of Americans say marijuana should be legal.

Certain groups of Americans are more inclined than others to support the legalization of marijuana. In order to better understand which groups of Americans are more inclined to support legalization, Gallup combined the results of three surveys, conducted in August 2001, November 2003, and October 2005*.

Gender, Age Shapes Support for Legalization

Support for marijuana legalization varies greatest by gender and age. Overall, younger Americans (aged 18 to 29) are essentially divided, with 47% saying marijuana should be legal and 50% saying it should not be. Support for legalization is much lower among adults aged 30 to 64 (35%) and those aged 65 and older (22%). Men (39%) are somewhat more likely than women (30%) to support the legalization of marijuana in the country.

When looking at the combined results by age and gender, the data show 44% of men aged 18 to 49 support the legalization of marijuana. This sentiment is lower among older men (33% for men aged 50 and older) and women of any age (34% for women aged 18 to 49 and 27% of women aged 50 and older).

Gallup found similar patterns in 1973, a few years after it first started asking the question. That year, men were also slightly more likely than women, by 18% to 13%, to support legalization. A third of 18- to 29-year-olds (34%) agreed with legalizing marijuana, while no more than 11% of adults aged 30 and older agreed. And, about one in four men aged 18 to 49 (24%) supported legalization, compared with 7% of men aged 50 and older, 18% of women aged 18 to 49, and 6% of women aged 50 and older.

The data make it clear that despite the gender and age differences that still persist, all subgroups are more likely to support legalized marijuana today than three decades ago.

Westerners Divided in Views of Legalization

Americans residing in the western parts of the country are more likely than those living elsewhere to support the legalization of marijuana. These differences perhaps result from the fact that six Western states have, in various ways, already legalized marijuana for medicinal use. Overall, the data show that Westerners are divided about marijuana, with 47% saying it should be legal and 49% saying it should not be. No more than a third of adults living in other parts of the country feel marijuana should be legal.

In 1973, Gallup found that residents in the East and West were more likely to support marijuana legalization than those in the Midwest and South. Roughly one in five Easterners (20%) and Westerners (22%) supported this idea, compared with 13% of Midwesterners and 10% of Southerners.

Church Attendance Related to Support

Only about one in six Americans who attend church or religious services weekly (17%) support the legalization of marijuana. Support is higher among those who attend less frequently — 30% among those who attend almost weekly or monthly and 49% among those who rarely or never go.

College-Educated Adults Give Slightly Higher Support for Legalization

Americans with some college education — from those who have attended at least one college course to those who have postgraduate degrees — are somewhat more likely than those without a college degree to say marijuana should be legal in the country. Thirty-seven percent of adults with a college education support legalization, compared with 31% of those with no college education.

The differences between these two groups were much more pronounced in 1973. At that time, 29% of college-educated adults supported legalization, compared with just 11% of those with no college.

Politics and Marijuana Legalization

Support for legalizing marijuana is much lower among Republicans than it is among Democrats or independents. One in five Republicans (21%) say marijuana should be made legal in this country, while 37% of Democrats and 44% of independents share this view.

When Gallup asked this question in 1973, independents (25%) were at least twice as likely as Democrats or Republicans to support this idea. However, at the time, there were only slight differences in support between Democrats (13%) and Republicans (9%).

The data also show differences by respondents’ self-described political ideology. Twenty-two percent of conservatives feel marijuana should be made legal, compared with 36% of moderates and a majority of liberals (54%).

*Results are based on telephone interviews with 2,034 national adults, aged 18 and older, conducted Aug. 3-5, 2001, Nov. 10-12, 2003, and Oct. 21-23, 2005. For results based on the total sample of national adults, one can say with 95% confidence that the maximum margin of sampling error is ±2 percentage points.

In addition to sampling error, question wording and practical difficulties in conducting surveys can introduce error or bias into the findings of public opinion polls.